进展期肝细胞癌患者的卡培他滨加顺铂的联合治疗OACSTPCD
Capecitabine plus cisplatin treatment in patients with advanced hepatocellular carcinoma
Objective:Hepatocellular carcinoma(HCC)is the sixth most common cancer in the wodd and the third leading cause of cancer related death globally.Parentral treatment of Egyptian patients of bilharziasis contributed to the high incidence of viral hepatitis,and subsequently liver cirrhosis and HCC.Capecitabine plus cisplatin protocol was evaluated regarding the efficacy and safety in patients with advanced HCC as first line chemotherapy.Methods:One hundred patie…查看全部>>
Manal M Abdel Wahab;Lobna R Ezz Elarab;Mohamed A Ezz Elarab
Radiation Oncology and Nuclear Medicine Department,Faculty of Medicine,Ain Shams University,Cairo,EgyptNational Hepatology and Tropical Medicine Research Institute,Cairo,Egypt
临床医学
cepecitabinecisplatinhepatocellular carcinoma(HCC)bilharziasisliver cirrhosis
cepecitabinecisplatinhepatocellular carcinoma(HCC)bilharziasisliver cirrhosis
《中德临床肿瘤学杂志（英文版）》 2010 (12)
718-723,6
评论